within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A02B_DrugsForPepticUlcerAndGastroOesophagealRefluxDis.A02BA08_Lafutidine;

model Lafutidine
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.85,
    Cl = 2.222222222222222e-06,
    adminDuration = 600,
    adminMass = 10 / 1000000,
    adminCount = 1,
    Vd = 0.00136,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.009166666666666667,
    Tlag = 10.200000000000001);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Lafutidine</td></tr><tr><td>ATC code:</td><td>A02BA08</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>10</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>1.36</td><td>L</td></tr>
    <tr><td>clearance:</td><td>8.0</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Lafutidine is a histamine H2-receptor antagonist used for the treatment of peptic ulcer and gastroesophageal reflux disease. It is approved and widely used in Japan and some Asian countries, but not approved in the United States or Europe.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult male volunteers following a single oral dose.</p><h4>References</h4><ol><li><p>Li, S, et al., &amp; Li, W (2016). Pharmacokinetic Properties of Oral Lafutidine Tablets and the Effect of Food on its Pharmacokinetics in Healthy Chinese Subjects. <i>Advances in therapy</i> 33(10) 1704–1714. DOI:<a href=\"https://doi.org/10.1007/s12325-016-0383-9\">10.1007/s12325-016-0383-9</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27444313/\">https://pubmed.ncbi.nlm.nih.gov/27444313</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.A.A02BA08 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Lafutidine;
